Léim chuig an ábhar
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Teanga
Gach réimse
Teideal
Údar
Ábhar
Gairmuimhir
ISBN/ISSN
Clib
AIMSIGH
CASTA
Rationale and design of the Tr...
Luaigh é seo
Seol mar théacs é seo
Seol é seo mar r-phost
Priontáil
Easpórtáil taifead
Easpórtáil chuig RefWorks
Easpórtáil chuig EndNoteWeb
Easpórtáil chuig EndNote
Buan-nasc
Rationale and design of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)
Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:
Bethel, M
,
Green, J
,
Califf, R
,
Holman, R
Formáid:
Conference item
Foilsithe / Cruthaithe:
2009
Stoc
Cur síos
Míreanna comhchosúla
Amharc foirne
Cur síos
Achoimre:
Míreanna comhchosúla
Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and established cardiovascular disease
de réir: Green, J, et al.
Foilsithe / Cruthaithe: (2013)
Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and established cardiovascular disease.
de réir: Green, J, et al.
Foilsithe / Cruthaithe: (2013)
Assessing the safety of sitagliptin in older participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)
de réir: Bethel, M, et al.
Foilsithe / Cruthaithe: (2017)
Pancreatic safety of sitagliptin in the TECOS Study.
de réir: Buse, J, et al.
Foilsithe / Cruthaithe: (2016)
Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS Trial.
de réir: Josse, R, et al.
Foilsithe / Cruthaithe: (2016)